Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
So lately we’ve been seeing ads for this birth-control pill called Yasmin, and even though it’s been for sale under that name, particularly in Europe, for some time, it strikes us as a really peculiar name for that kind of drug. (The FDA is thinking of approving it in the U.S. in a low-dose version, which is bound to spur more advertising—and broader brand recognition for the product—in late 2005.)
We get the idea here. Women want to have warm and fuzzy associations with their birth-control pills, to make it seem less like they’re taking a prescription drug.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in